Global Therapeutic BCG Vaccines Market 2026 reaching $80.4 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Therapeutic BCG Vaccines Market Across 2026–2030?

The market size for therapeutic bcg vaccines has exhibited strong expansion in recent years. It is projected to increase from $59.09 billion in 2025 to $62.77 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.2%. The historical growth in this market can be ascribed to factors like high tb prevalence, advancements in immunotherapy research, restricted vaccination coverage, governmental health programs, and enhanced awareness of bcg benefits.

The therapeutic bcg vaccines market is anticipated to experience substantial expansion over the next few years. It is projected to achieve a size of $80.4 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.4%. This notable increase during the forecast period stems from several factors, including a surging demand for personalized vaccines, ongoing technological advancements in vaccine delivery, a heightened focus on immuno-oncology applications, the expansion of public health programs, and increasing investment in biotech innovations. Furthermore, prominent trends expected in the forecast period involve the development of personalized bcg therapy, innovations in vaccine delivery, expanded research within tb immunotherapy, the integration of combination therapies with bcg, and the establishment of government-funded immunization programs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Therapeutic BCG Vaccines Market?

The global increase in tuberculosis (TB) cases is set to boost the expansion of the therapeutic BCG vaccine market in the coming years. Tuberculosis (TB) is a contagious and potentially severe disease predominantly affecting the lungs, which can be transmitted between individuals through airborne bacterial droplets from coughing or sneezing. BCG vaccines work by stimulating the immune system to combat infection without causing TB, as they contain weakened germs. These vaccines reliably safeguard against severe forms of TB, including adolescent TB meningitis. The protective action of the BCG vaccine against tuberculosis, which aids in fighting infection, has led to a rise in the adoption of therapeutic BCG vaccines. As an illustration, in February 2024, the UK Health Security Agency, a UK-based government body, released a report indicating that tuberculosis (TB) cases in England saw a 10.7% rise in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Consequently, the growing incidence of tuberculosis (TB) cases globally is a significant factor propelling the growth of the therapeutic BCG vaccine market.

What Segmentation Levels Are Considered In The Therapeutic BCG Vaccines Market?

The therapeutic bcg vaccines market covered in this report is segmented –

1) By Type: Therapy BCG, Other Types

2) By Demographics: Pediatrics, Adults

3) By End Use: Hospitals, Clinics, Other End Users

What Trends Are Projected To Affect The Therapeutic BCG Vaccines Market?

Leading companies within the therapeutic BCG vaccine market are concentrating on developing novel vaccines for various medical conditions, including BCG immunotherapy, to broaden their customer base and cater to increasing patient demands. BCG (Bacillus Calmette-Guérin) immunotherapy involves utilizing the BCG vaccine as an immunotherapeutic treatment for specific cancer types, particularly bladder cancer. For example, in July 2023, The Serum Institute of India, an Indian biotechnology and biopharmaceuticals firm, obtained government authorization to export its BCG vaccine to Canada for immunotherapeutic application in bladder cancer treatment. This live, freeze-dried formulation, originating from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is purposed for intravenous instillation. The vaccine comes in 40 mg and 80 mg dosages. As a crucial element of the therapy, the vaccine is delivered straight into the bladder via a catheter, staying within the bladder lining for a predetermined period. This precise method seeks to effectively affect cancer cells while reducing its influence on other bodily areas.

Which Leading Firms Are Contributing To The Growth Of The Therapeutic BCG Vaccines Market?

Major companies operating in the therapeutic bcg vaccines market are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, Bharat Biotech International Ltd., Shanghai Institute of Biological Products Co. Ltd., Instituto Butantan, BioCen, Panacea Biotec Ltd., Institute Pasteur de Tunis, Korean BCG Vaccine Institute

Read the full therapeutic bcg vaccines market report here:

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Which Regions Are Projected To Dominate The Therapeutic BCG Vaccines Market In The Coming Years?

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2025. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Therapeutic BCG Vaccines Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

Browse Through More Reports Similar to the Global Therapeutic BCG Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795